Biotechnology News

SANTA CLARA, Calif., July 21, 2020 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex...

EMERYVILLE, Calif., July 21, 2020 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc., (Nasdaq: BLI) a leader in Digital Cell Biology, today announced the closing of its initial public offering of 9,315,000...

SAN DIEGO and TORONTO, July 21, 2020 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (Nasdaq: APTO; TSX: APS), a clinical-stage company developing highly differentiated therapeutics that target the...

WALTHAM, Mass., July 21, 2020 (GLOBE NEWSWIRE) -- Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX), a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel...

39% (11 SAEs in 28 Patients) in Placebo Arm as Compared to Only 14% (8 SAEs in 56 Patients) in Leronlimab Arm Reported Serious Adverse Events (SAEs), Which Were Unrelated to Leronlimab. The Efficacy...

ACTIVITÉ DU PREMIER SEMESTRE 2020 EN TRES FORTE PROGRESSION Forte Progression du chiffre d’affaires consolidé semestriel de +111% à 62,2 M€31 M€ réalisés avec les tests et équipements liés à...

VERY STRONG GROWTH OF BUSINESS DURING THE FIRST HALF OF 2020 Strong +111% growth of consolidated sales at € 62.2 million€ 31 million sales of tests and equipements related to the COVID-19...

Company announcement no. 20 - 20 20 July 2020 Transactions in connection with share buyback program On May 25, 2020 NTG Nordic Transport Group (“NTG”) announced a share buyback program, as...

SEATTLE, July 21, 2020 (GLOBE NEWSWIRE) -- SEngine Precision Medicine, a precision oncology company revolutionizing cancer diagnostics and drug discovery by pre-testing drugs on...

SAN DIEGO, July 21, 2020 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (OTCQB: AXIM) ("AXIM® Biotech," "AXIM" or "the Company"), an international healthcare solutions company targeting oncological...